This company has been acquired
Natus Medical Balance Sheet Health
Financial Health criteria checks 6/6
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | 24x |
| Cash | US$84.29m |
| Equity | US$430.89m |
| Total liabilities | US$137.19m |
| Total assets | US$568.08m |
Recent financial health updates
Does Natus Medical (NASDAQ:NTUS) Have A Healthy Balance Sheet?
Aug 02
Is Natus Medical (NASDAQ:NTUS) Using Debt Sensibly?
Feb 15
Recent updates
Novanta to replace Six Flags Entertainment in S&P MidCap 400, Six Flags to replace Natus Medical in S&P SmallCap 600
Jul 22Some Investors May Be Worried About Natus Medical's (NASDAQ:NTUS) Returns On Capital
Mar 04Some Investors May Be Worried About Natus Medical's (NASDAQ:NTUS) Returns On Capital
Nov 08We Like Natus Medical's (NASDAQ:NTUS) Earnings For More Than Just Statutory Profit
Aug 13Does Natus Medical (NASDAQ:NTUS) Have A Healthy Balance Sheet?
Aug 02We Think Shareholders Are Less Likely To Approve A Pay Rise For Natus Medical Incorporated's (NASDAQ:NTUS) CEO For Now
Jun 10Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)
May 05Is Natus Medical (NASDAQ:NTUS) Using Debt Sensibly?
Feb 15Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)
Jan 11Reflecting on Natus Medical's (NASDAQ:NTUS) Share Price Returns Over The Last Five Years
Dec 07Financial Position Analysis
Short Term Liabilities: NTUS's short term assets ($286.8M) exceed its short term liabilities ($112.9M).
Long Term Liabilities: NTUS's short term assets ($286.8M) exceed its long term liabilities ($24.3M).
Debt to Equity History and Analysis
Debt Level: NTUS is debt free.
Reducing Debt: NTUS has no debt compared to 5 years ago when its debt to equity ratio was 35.5%.
Debt Coverage: NTUS has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: NTUS has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/07/22 00:08 |
| End of Day Share Price | 2022/07/20 00:00 |
| Earnings | 2022/03/31 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Natus Medical Incorporated is covered by 14 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Daniel Owczarski | Avondale Partners |
| Raymond Myers | Benchmark Company |
| Lawrence Solow | CJS Securities, Inc. |